RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study

URN to cite this document:: urn:nbn:de:bvb:355-epub-293079
DOI to cite this document:: 10.5283/epub.29307

Beier, Christoph P. ; Schmid, Christina ; Gorlia, Thierry ; Kleinletzenberger, Christine ; Beier, Dagmar ; Grauer, Oliver ; Steinbrecher, Andreas ; Hirschmann, Birgit ; Brawanski, Alexander ; Dietmaier, Christopher ; Jauch-Worley, Tanja ; Kölbl, Oliver ; Pietsch, Torsten ; Proescholdt, Martin A. ; Rümmele, Petra ; Muigg, Armin ; Stockhammer, Günther ; Hegi, Monika ; Bogdahn, Ulrich ; Hau, Peter

Preview

PDF
(233kB)

Date of publication of this fulltext: 16 Jan 2014 11:37

Alternative links to fulltext:Pubmed DOI

Details

Preview

Export bibliographical data

Abstract

Together, the investigated combination is tolerable and feasible. Neither the addition of PEG-Dox nor the prolonged administration of Temozolomide resulted in a meaningful improvement of the patient's outcome as compared to the EORTC26981/NCIC-CE.3 data.

Owner only: item control page

Download Statistics